product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
NIFK Antibody (18E148) - Azide Free
catalog :
NBP2-33233
quantity :
0.1 mg
price :
459 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
1.80E+149
reactivity :
human
application :
western blot
more info or order :
product information
master code :
NBP2-33233
SKU :
NBP2-33233
product name :
NIFK Antibody (18E148) - Azide Free
unit size :
0.1 mg
description :
The NIFK Antibody (18E148) - Azide and BSA Free from Novus is a mouse monoclonal antibody to NIFK. This antibody reacts with human. The NIFK Antibody (18E148) - Azide and BSA Free has been validated for the following applications: Western Blot.
target :
NIFK
category :
Primary Antibodies
buffer :
PBS - BSA free
clonality :
Monoclonal
clone :
1.80E+149
conjugate :
Unconjugated
host :
Mouse
immunogen :
This antibody was developed against a synthetic peptide corresponding to a portion of human NIFK between amino acids 100-200.
isotype :
IgG1
purity :
Protein G purified
species :
Human
gene symbol :
NIFK
applications :
Western Blot
USD :
459 USD
alt names :
hNIFK, MKI67 (FHA domain) interacting nucleolar phosphoprotein, MKI67 FHA domain-interacting nucleolar phosphoprotein, NIFKNOPP34, Nopp34, Nucleolar phosphoprotein Nopp34, Nucleolar protein interacting with the FHA domain of pKI-67
storage :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
more info or order :
company information

Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.
related products
browse more products
questions and comments